Gilead agrees to pay $247M to set­tle HIV drug case that al­leged com­pe­ti­tion block­ing

De­tails of a pro­posed HIV set­tle­ment with Gilead are now pub­lic, but its fate hinges on a fed­er­al judge’s OK next month.

KPH Health­care Ser­vices, a plain­tiff in a years-long an­titrust case cen­tered around Gilead and ac­cess to HIV med­i­cines, filed a pro­posed or­der in US Dis­trict Court for the Dis­trict of North­ern Cal­i­for­nia on Wednes­day. In the pro­posed or­der and fil­ing, the set­tle­ment would re­quire Gilead to pay $246.8 mil­lion in­to a set­tle­ment fund.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER